Multiple-dose exenatide XTEN vs exenatide in type 2 diabetes mellitus.

Trial Profile

Multiple-dose exenatide XTEN vs exenatide in type 2 diabetes mellitus.

Planning
Phase of Trial: Phase I

Latest Information Update: 09 Jun 2012

At a glance

  • Drugs Exenatide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Jun 2012 This trial is still being planned, according to a Diartis Pharmaceuticals media release.
    • 16 Feb 2011 This trial is expected to start in 2011.
    • 22 Jun 2010 This study is planned to begin in the fourth quarter of 2010, according to a Versartis media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top